LEVEL 4 J04AB02

Δραστικές

Φάρμακα

  • DRUGBANK - Rifampin
  • indication:

    For the treatment of Tuberculosis and Tuberculosis-related mycobacterial infections.

  • pharmacology:

  • mechanism:

    Rifampin acts via the inhibition of DNA-dependent RNA polymerase, leading to a suppression of RNA synthesis and cell death.

  • toxicity:

    LD<sub>50</sub>=1570 mg/kg (rat), chronic exposure may cause nausea and vomiting and unconsciousness

  • absorprion:

    Well absorbed from gastrointestinal tract.

  • halflife:

    3.35 (+/- 0.66) hours

  • roouteelimination:

    Less than 30% of the dose is excreted in the urine as rifampin or metabolites.

  • volumedistribution:

  • clearance:

    * 0.19 +/- 0.06 L/hr/kg [300 mg IV] * 0.14 +/- 0.03 L/hr/kg [600 mg IV]